Abbott Seeks to Expand Its Libre Glucose Monitor Franchise Well Beyond Diabetes Patients
In our view, the biggest risks Abbott faces include ongoing difficulties with its left ventricular assist devices, and the potential commercial success of its Libre franchise, which includes planned ...